(Q37528458)

20 August 2017

1 reference

title

Type I IFNs and their role in the development of autoimmune diseases (English)

1 reference

20 August 2017

Laura M Burdick

1

1 reference

20 August 2017

Najwa Somani

series ordinal

2

1 reference

20 August 2017

Ally-Khan Somani

series ordinal

3

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

Expert Opinion on Drug Safety

20 August 2017

1 reference

20 August 2017

8

1 reference

20 August 2017

4

1 reference

20 August 2017

459-472

1 reference

TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity

20 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Gene expression profiling in human autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Type I interferons (alpha/beta) in immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Evidence for a role of type I interferons in the pathogenesis of dermatomyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Microarray analysis of gene expression in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interferons as pathogenic effectors in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interferons at age 50: past, current and future impact on biomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interferon-induced granulomatous lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interferon-beta1A-induced polyarthritis in a patient with the HLA-DRB1*0404 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interferon signalling network in innate defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Mechanisms of type-I interferon signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

ISG15: the immunological kin of ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Protein ISGylation modulates the JAK-STAT signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Immunoregulatory properties of ISG15, an interferon-induced cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Roles of genetic variations in signalling/immunoregulatory molecules in susceptibility to systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

The genetics and biology of Irf5-mediated signaling in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interferon: pharmacokinetics and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

The impact of PEGylation on biological therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interferon-beta: mechanism of action and dosing issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Induction of clinical autoimmune disease by therapeutic interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Down-regulation of MHC class I is a property common to papillomavirus E5 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Effect of human cytomegalovirus on expression of MHC class I-related chains A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Subversion of host cell signalling by the protozoan parasite Leishmania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interferons alpha and beta as immune regulators--a new look

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Natural interferon alpha/beta-producing cells link innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Clinical toxicity of the interferons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Dermatomyositis after interferon alpha treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

From T to B and back again: positive feedback in systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Association of polymorphisms in interferon regulatory factor 5 gene with rheumatoid arthritis: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Type I interferon: potential therapeutic target for psoriasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Psoriasis induced by topical imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Cross-regulation of TNF and IFN-alpha in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Biologic therapy (TNF-alpha antagonists)-induced psoriasis: a cytokine imbalance between TNF-alpha and IFN-alpha?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Sarcoidosis in patients with mixed connective tissue disease: clinical, genetic, serological and histological observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

The role of innate immunity in autoimmune tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

The consequences of apoptosis in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Cell damage and autoimmunity: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

The Nature and Nurture of Common Autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Peptide register shifting within the MHC groove: theory becomes reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Understanding how combinations of HLA and KIR genes influence disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

A case of polymyositis with dilated cardiomyopathy associated with interferon alpha treatment for hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Interferon-induced vitiligo in a patient with chronic viral hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066726

10.1517/14740330903066726

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference